Last Price
308.05
Today's Change
+2.51 (0.82%)
Day's Change
306.35 - 309.48
Trading Volume
724,972
Market Cap
148 Billion
Shares Outstanding
483 Million
Avg Volume
728,193
Avg Price (50 Days)
292.60
Avg Price (200 Days)
280.15
PE Ratio
40.01
EPS
7.70
Earnings Announcement
13-Aug-2024
Previous Close
305.54
Open
307.94
Day's Range
306.35 - 309.48
Year Range
228.65 - 313.55
Trading Volume
724,972
1 Day Change
0.82%
5 Day Change
-0.62%
1 Month Change
4.37%
3 Month Change
12.71%
6 Month Change
5.04%
Ytd Change
6.85%
1 Year Change
15.07%
3 Year Change
5.46%
5 Year Change
34.61%
10 Year Change
361.43%
Max Change
37149.09%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.